Orin Green Financial’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $90.6K | Buy |
61,200
+11,200
| +22% | +$16.6K | 0.04% | 76 |
|
|
2025
Q1 | $128K | Buy |
+50,000
| New | +$128K | 0.06% | 72 |
|
|
2024
Q4 | – | Sell |
-72,000
| Closed | -$73.4K | – | 75 |
|
|
2024
Q3 | $73.4K | Hold |
72,000
| – | – | 0.03% | 80 |
|
|
2024
Q2 | $84.2K | Buy |
+72,000
| New | +$84.2K | 0.04% | 74 |
|
|
2024
Q1 | – | Sell |
-80,000
| Closed | -$142K | – | 76 |
|
|
2023
Q4 | $142K | Hold |
80,000
| – | – | 0.07% | 74 |
|
|
2023
Q3 | $133K | Buy |
80,000
+19,850
| +33% | +$33K | 0.07% | 67 |
|
|
2023
Q2 | $120K | Buy |
+60,150
| New | +$120K | 0.06% | 67 |
|